Immunological mechanisms in opsoclonus-myoclonus associated neuroblastoma
- PMID: 18571942
- DOI: 10.1016/j.ejpn.2008.04.012
Immunological mechanisms in opsoclonus-myoclonus associated neuroblastoma
Abstract
Opsoclonus-myoclonus syndrome is a rare paraneoplastic disorder, often associated with malignancies including neuroblastoma (NB), the most common solid tumor of childhood derived from the sympathetic nervous system. The pathogenesis of this syndrome is still undefined but is suspected to be the result of an autoimmune response. In this respect, different autoantibodies binding to neurons or cerebellar Purkinje cells have been detected in OMS-associated NB. In addition, immunohistochemical analysis of NB affecting children with OMS demonstrated the presence of interstitial or perivascular lymphoid infiltrates resembling secondary lymphoid follicles. Immunophenotyping of these lymphoid cells showed the existence of a mesh of CD21(+) follicular dendritic cells, numerous CD20(+) B lymphocytes in the germinal center and the mantle zone of the follicle and few CD3(+) T lymphocytes in a perifollicular area. Since information is lacking about the mechanism involved in ectopic lymphoid neogenesis of OMS-associated NB, we are currently investigating the role of different chemokines and their cognate receptors in the recruitment of lymphoid cells within tumor mass of OMS-associated NB. Here, we review some recent data about the pathogenesis of OMS-associated with NB.
Similar articles
-
Role of BAFF in Opsoclonus-Myoclonus syndrome, a bridge between cancer and autoimmunity.J Leukoc Biol. 2013 Jul;94(1):183-91. doi: 10.1189/jlb.0213106. Epub 2013 Apr 22. J Leukoc Biol. 2013. PMID: 23610147
-
Autoantibodies in childhood opsoclonus-myoclonus syndrome.J Neuroimmunol. 2008 Sep 15;201-202:221-6. doi: 10.1016/j.jneuroim.2008.05.033. Epub 2008 Aug 6. J Neuroimmunol. 2008. PMID: 18687475
-
New autoantibodies in pediatric opsoclonus myoclonus syndrome.Ann N Y Acad Sci. 2007 Sep;1110:256-60. doi: 10.1196/annals.1423.027. Ann N Y Acad Sci. 2007. PMID: 17911440
-
Opsoclonus-myoclonus syndrome associated with neuroblastoma: Insights into antitumor immunity.Pediatr Blood Cancer. 2022 Nov;69(11):e29949. doi: 10.1002/pbc.29949. Epub 2022 Sep 12. Pediatr Blood Cancer. 2022. PMID: 36094353 Review.
-
An update on opsoclonus.Curr Opin Neurol. 2007 Feb;20(1):25-31. doi: 10.1097/WCO.0b013e3280126b51. Curr Opin Neurol. 2007. PMID: 17215685 Review.
Cited by
-
Paraneoplastic neurologic disorders in children.Curr Neurol Neurosci Rep. 2011 Apr;11(2):187-94. doi: 10.1007/s11910-010-0169-4. Curr Neurol Neurosci Rep. 2011. PMID: 21161703
-
Demographic, Clinical, and Immunologic Features of 389 Children with Opsoclonus-Myoclonus Syndrome: A Cross-sectional Study.Front Neurol. 2017 Sep 11;8:468. doi: 10.3389/fneur.2017.00468. eCollection 2017. Front Neurol. 2017. PMID: 28959231 Free PMC article.
-
Treatment and revaccination of children with paraneoplastic opsoclonus-myoclonus-ataxia syndrome and neuroblastoma: The Memorial Sloan Kettering experience.Pediatr Blood Cancer. 2020 Aug;67(8):e28319. doi: 10.1002/pbc.28319. Epub 2020 Jun 15. Pediatr Blood Cancer. 2020. PMID: 32543116 Free PMC article.
-
A Case of Paraneoplastic Neurological Syndrome Leading to the Diagnosis of Large Cell Neuroendocrine Carcinoma From Opsoclonus-Myoclonus Syndrome.Cureus. 2023 Nov 16;15(11):e48911. doi: 10.7759/cureus.48911. eCollection 2023 Nov. Cureus. 2023. PMID: 38106804 Free PMC article.
-
Long-term neurological outcomes of children with neuroblastoma with opsoclonus-myoclonus syndrome.Transl Pediatr. 2022 Mar;11(3):368-374. doi: 10.21037/tp-21-519. Transl Pediatr. 2022. PMID: 35378965 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical